Be part of the knowledge.™

Spotlight on Multiple Sclerosis

Showcasing the latest news and clinical breakthroughs in care, Spotlight on Multiple Sclerosis shines an educational beacon for healthcare professionals dedicated to improving patients’ quality of life and outcomes.

Here you’ll find leading neurologists and other allied healthcare professionals sharing research updates and novel insights on collaborative, evidence-based practices to slow the disease course, treat relapses, manage symptoms, and improve function and safety.

11

LikeLikedUnlike

Episodes 1-15 of 37

The Future of MS Management: Novel Agents and Clinical Approaches
NeuroFrontiers
The Future of MS Management: Novel Agents and Clinical Approaches
- Marisa McGinley, DO
  Peer
MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
NeuroFrontiers
MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
NeuroFrontiers
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
NeuroFrontiers
Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
NeuroFrontiers
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiers
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
advertisement
Understanding MS: Managing Hidden and Overlooked Symptoms
NeuroFrontiers
Understanding MS: Managing Hidden and Overlooked Symptoms
- Marisa McGinley, DO
  Peer
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
NeuroFrontiers
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
- Marisa McGinley, DO
  Peer
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
NeuroFrontiers
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
- Marisa McGinley, DO
  Peer
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
NeuroFrontiers
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
NeuroFrontiers
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
NeuroFrontiers
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
advertisement
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
  Peer
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended